Cytoplasmic domain requirement for incorporation of a foreign envelope protein into vesicular stomatitis virus.
about
Interactions of the cytoplasmic domains of human and simian retroviral transmembrane proteins with components of the clathrin adaptor complexes modulate intracellular and cell surface expression of envelope glycoproteinsRole of rubella virus glycoprotein domains in assembly of virus-like particles.Chimeric measles viruses with a foreign envelopeFunctional role of hepatitis C virus chimeric glycoproteins in the infectivity of pseudotyped virusCoronavirus particle assembly: primary structure requirements of the membrane protein.Hybrid alphavirus-rhabdovirus propagating replicon particles are versatile and potent vaccine vectorsCharacterization of Vesicular Stomatitis Virus Pseudotypes Bearing Essential Entry Glycoproteins gB, gD, gH, and gL of Herpes Simplex Virus 1.The M2 ectodomain is important for its incorporation into influenza A virions.Identification of the respiratory syncytial virus proteins required for formation and passage of helper-dependent infectious particles.Influenza virus hemagglutinin and neuraminidase cytoplasmic tails control particle shape.Virus maturation by budding.Measles viruses with altered envelope protein cytoplasmic tails gain cell fusion competence.A single-cycle vaccine vector based on vesicular stomatitis virus can induce immune responses comparable to those generated by a replication-competent vector.A novel, live-attenuated vesicular stomatitis virus vector displaying conformationally intact, functional HIV-1 envelope trimers that elicits potent cellular and humoral responses in mice.Recombinant vesicular stomatitis viruses from DNA.Vesicular stomatitis virus-simian retrovirus type 2 vaccine protects macaques from detectable infection and B-cell destructionDevelopment of a novel surrogate virus for human T-cell leukemia virus type 1: inhibition of infection by osteoprotegerin.The envelope glycoprotein of human immunodeficiency virus type 2 enhances viral particle release: a Vpu-like factor?Mutations in the matrix protein of human immunodeficiency virus type 1 inhibit surface expression and virion incorporation of viral envelope glycoproteins in CD4+ T lymphocytesSpecific targeting to CD4+ cells of recombinant vesicular stomatitis viruses encoding human immunodeficiency virus envelope proteins.High-efficiency incorporation of functional influenza virus glycoproteins into recombinant vesicular stomatitis viruses.An internalization signal in the simian immunodeficiency virus transmembrane protein cytoplasmic domain modulates expression of envelope glycoproteins on the cell surfaceRetargeting Oncolytic Vesicular Stomatitis Virus to Human T-Cell Lymphotropic Virus Type 1-Associated Adult T-Cell LeukemiaPseudotyping of murine leukemia virus with the envelope glycoproteins of HIV generates a retroviral vector with specificity of infection for CD4-expressing cells.Mutations in the membrane-spanning domain of the human immunodeficiency virus envelope glycoprotein that affect fusion activity.Postassembly cleavage of a retroviral glycoprotein cytoplasmic domain removes a necessary incorporation signal and activates fusion activity.Infectious Entry Pathway Mediated by the Human Endogenous Retrovirus K Envelope Protein.A system for functional analysis of Ebola virus glycoprotein.The frantic play of the concealed HIV envelope cytoplasmic tail.Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles.Specific infection of CD4+ target cells by recombinant rabies virus pseudotypes carrying the HIV-1 envelope spike protein.Characterization of nonpathogenic, live, viral vaccine vectors inducing potent cellular immune responses.The hypervariable region 1 of the E2 glycoprotein of hepatitis C virus binds to glycosaminoglycans, but this binding does not lead to infection in a pseudotype system.A tyrosine-based motif in the cytoplasmic domain of the alphavirus envelope protein is essential for buddingFunctional role of the cytoplasmic tail domain of the major envelope fusion protein of group II baculoviruses.Replication-competent rhabdoviruses with human immunodeficiency virus type 1 coats and green fluorescent protein: entry by a pH-independent pathway.Acquisition of complement resistance through incorporation of CD55/decay-accelerating factor into viral particles bearing baculovirus GP64.Mokola virus glycoprotein and chimeric proteins can replace rabies virus glycoprotein in the rescue of infectious defective rabies virus particles.Influenza virus hemagglutinin and neuraminidase glycoproteins stimulate the membrane association of the matrix protein.Efficient pseudotyping of murine leukemia virus particles with chimeric human foamy virus envelope proteins
P2860
Q24517016-DF28A87A-7928-4BAA-893C-9220EC5AB9AFQ24517120-2F7EE163-09CA-4625-9C52-711BEE63E55BQ27469529-48564BF5-389D-4120-B4B4-F489B384E1D8Q27469536-2CB664AF-83C7-4AA2-8A44-0241AB66EF46Q27469560-04410FB1-401B-4C89-BB89-028F1D71046AQ27485876-098A54F7-828F-42B0-852A-207E08935DA4Q30353044-A4A4501C-6FF5-4DEC-9DAE-3F683FB6C531Q33782503-8AC58834-29DA-4C7B-B870-9086FFCBDF57Q33785124-81996704-8989-479C-89F7-CD7CD4505A25Q33886239-3C27793E-22BA-4760-8D99-06F3CE238635Q34068037-3D3EF85C-7B16-4030-B09B-F07698C620D0Q34069549-7BEE3AFE-F773-4359-ACEB-186AE2913C83Q34092753-66825C67-84A1-428E-ABD1-ABA2840B36B9Q34172295-48097E95-A846-489A-A89C-2FF333B82992Q34337129-DD9038B2-639F-4024-806D-508E052AC99EQ35077051-EA2E761C-ACE0-4FB7-9B1D-830931A2738FQ35155045-18D1AB95-2FCA-4665-A657-E1D5FE00457DQ35854386-D9A2976E-5912-4019-945E-CC22ECC7A22DQ35877383-35C43C37-A6DC-4E58-B30A-1C2D4E1277F7Q35887822-AB69CD16-CE15-4D53-8667-8E654307CB6BQ35889961-F4FE061B-4A2D-4225-A394-1F8A7EA59477Q36236526-6D23250D-9252-427B-B8DD-C9D6EFA3EB76Q36281149-6179C1B1-4E9C-4E01-8A0F-1BF19EFDB2A8Q36551563-2470D703-3736-4898-9D3C-C8F9BEFF3A72Q36620954-E4D3E094-1B1C-48B1-999A-3AA859EC96CBQ36623006-D41FB884-A5B7-4160-A53C-D2602278BDEFQ36694049-A47E2158-BCAA-4395-BD57-11175A91F5CCQ36831630-45F4E59C-7B6A-46CB-A9DD-304463BDEEF9Q36940646-178A744D-76EE-4387-8FF3-2CCD50064D25Q37249987-09DAC6DC-7251-4D9E-B1EA-92E14BA81F64Q37250302-0B567461-1166-4795-8E6F-B896F17631D1Q37348721-A19AE614-0A73-4FF4-83F0-91E8BD96B28DQ37422843-15844EC8-BCB7-4EF5-A3FD-CAB42F730E98Q37636103-FBC77F43-314D-46BF-847A-9557F21CF3D5Q39304502-CA313581-DDA7-406F-ACA6-3D5678C96C9FQ39595495-6E0CC3A5-2D0D-4A06-B3A1-E8B71B11AFADQ39609813-2B2E28FA-939F-469F-9BF9-B853A14105CEQ39869015-C1639A16-1EBC-4F63-862F-FBC7A8AE0633Q39876368-4BE24674-EE9E-4069-BB11-77139C8817BEQ39880036-004777B0-221D-44E0-9894-E004E4602E08
P2860
Cytoplasmic domain requirement for incorporation of a foreign envelope protein into vesicular stomatitis virus.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Cytoplasmic domain requirement ...... to vesicular stomatitis virus.
@ast
Cytoplasmic domain requirement ...... to vesicular stomatitis virus.
@en
type
label
Cytoplasmic domain requirement ...... to vesicular stomatitis virus.
@ast
Cytoplasmic domain requirement ...... to vesicular stomatitis virus.
@en
prefLabel
Cytoplasmic domain requirement ...... to vesicular stomatitis virus.
@ast
Cytoplasmic domain requirement ...... to vesicular stomatitis virus.
@en
P2860
P1433
P1476
Cytoplasmic domain requirement ...... nto vesicular stomatitis virus
@en
P2093
P2860
P304
P407
P577
1993-01-01T00:00:00Z